Congenital nasolacrimal duct obstruction: clinical guideline.
Sasaki T, Matsumura N, Miyazaki C, Kamao T, Yokoi N, Fujimoto M, Hayami M, Iwasaki A, Mimura M, Murata A, Nakayama T, Shinomiya K, Tanaka H, Ueta Y; Congenital Nasolacrimal Duct Obstruction: Clinical Guideline Preparation Team; Committee for Congenital Nasolacrimal Duct Obstruction Clinical Guideline.
Jpn J Ophthalmol. 2024 Jul;68(4):367-388. doi: 10.1007/s10384-024-01064-4. Epub 2024 Aug 16.
Treatment of Congenital Nasolacrimal Duct Obstruction.
Nelson LB.
J Pediatr Ophthalmol Strabismus. 2016 Sep 1;53(5):270. doi: 10.3928/01913913-20160829-01.
Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO).
Ali MJ.
Prog Retin Eye Res. 2023 Sep;96:101193. doi: 10.1016/j.preteyeres.2023.101193. Epub 2023 Jul 1.
Branchiooculofacial Syndrome.
Lin AE, Haldeman-Englert CR, Milunsky JM.
2011 May 31 [updated 2023 Sep 28]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.
Common management of congenital nasolacrimal duct obstruction.
Nelson LB.
J Pediatr Ophthalmol Strabismus. 2015 Jan-Feb;52(1):12. doi: 10.3928/01913913-20141230-04.
The lacrimal system.
Örge FH, Boente CS.
Pediatr Clin North Am. 2014 Jun;61(3):529-39. doi: 10.1016/j.pcl.2014.03.002.
Congenital nasolacrimal duct obstruction.
Ogawa GS, Gonnering RS.
J Pediatr. 1991 Jul;119(1 Pt 1):12-7. doi: 10.1016/s0022-3476(05)81031-5.
Endoscopy changing the treatment of congenital nasolacrimal duct obstruction.
Schellini SA, Akaishi PMS.
Arq Bras Oftalmol. 2024 May 27;87(3):e20240087. doi: 10.5935/0004-2749.2024-0087. eCollection 2024.
Congenital inner eyelid folds.
Millett M, Hyasat JG, Lueder GT.
Ophthalmic Genet. 2023 Aug;44(4):401-402. doi: 10.1080/13816810.2022.2127151. Epub 2023 Jan 13.
The Ophthalmic Manifestations of Down Syndrome.
Sun E, Kraus CL.
Children (Basel). 2023 Feb 9;10(2):341. doi: 10.3390/children10020341.
